- FMC Corporation, headquartered in Philadelphia, Pennsylvania, specializes in agricultural sciences, particularly in crop protection and nutrient management, with a focus on innovative active ingredients like Rynaxypyr.
- In February 2026, FMC announced a strategic review to explore options including a potential sale of the company, while also aiming to pay down over $1 billion in debt through asset sales and licensing agreements.
- The company reported a decline in Q4 2025 sales to $1.08 billion, with key products generating approximately $2.2 billion in core product sales, and it has seen growth in new active ingredients from $130 million in 2024 to $200 million in 2025.
- FMC's ideal buyer includes agricultural producers and distributors seeking effective crop protection solutions, particularly those looking to enhance competitiveness and manage costs amid market challenges.
FMC's workforce is organized into 13 departments, with the largest being Health Services, which employs 54 individuals. Operations follows with a headcount of 15, while the Executive department comprises 5 employees. The distribution of personnel across departments indicates a diverse functional balance, with a significant portion of staff categorized under 'Other' at 71, reflecting various specialized roles within the organization.
The company operates across 26 locations, with Philadelphia, PA, housing the largest concentration of employees at 35. Other notable locations include Carteret, NJ, and Woodland Hills, CA, each with 3 employees. The 'Other' category accounts for a substantial 91 employees, indicating a distributed workforce across multiple sites, which may enhance operational flexibility and regional presence.
